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ABSTRACT
The Epigenomics database at the National Center
for Biotechnology Information (NCBI) is a new
resource that has been created to serve as a
comprehensive public resource for whole-genome
epigenetic data sets (www.ncbi.nlm.nih.gov/
epigenomics). Epigenetics is the study of stable
and heritable changes in gene expression that
occur independently of the primary DNA sequence.
Epigenetic mechanisms include post-translational
modifications of histones, DNA methylation, chro-
matin conformation and non-coding RNAs. It has
been observed that misregulation of epigenetic
processes has been associated with human
disease. We have constructed the new resource by
selecting the subset of epigenetics-specific data
from general-purpose archives, such as the Gene
Expression Omnibus, and Sequence Read
Archives, and then subjecting them to further
review, annotation and reorganization. Raw data is
processed and mapped to genomic coordinates to
generate ‘tracks’ that are a visual representation of
the data. These data tracks can be viewed using
popular genome browsers or downloaded for local
analysis. The Epigenomics resource also provides
the user with a unique interface that allows for
intuitive browsing and searching of data sets
based on biological attributes. Currently, there are
69 studies, 337 samples and over 1100 data tracks
from five well-studied species that are viewable and
downloadable in Epigenomics.
INTRODUCTION
Interest in the ﬁeld of epigenetics has exploded over the
previous decade. Epigenetics, strictly deﬁned, refers to the
study of stable and heritable changes in gene expression
that are not mediated by the primary DNA sequence (1,2).
Epigenetic mechanisms participate in processes such as
regulating gene expression, homologous recombination
and DNA repair. Individual epigenetic features are
often called ‘marks’ because they are stably tied to
speciﬁc genomic locations and may be propagated
through many rounds of cell division, yet have the
ability to be ‘erased’ later as cells undergo differentiation
or are exposed to extra-cellular stimuli and environmental
cues (3–6). Several types of epigenetic marks have been
identiﬁed and intensely studied. These include post-
translational modiﬁcations of histone proteins, DNA
methylation, chromatin organization (DNase hypersensi-
tivity) and non-coding regulatory RNA (3). Just as
ordinary mutations are known to contribute to disease,
so too can corruption of normal epigenetic states
(‘epimutations’). Indeed, many cancers, degenerative
diseases and metabolic disorders have been shown to be
the result of mis-targeting of DNA methylation or
deﬁciencies in pathways for histone modiﬁcation (7–9).
We may consider the collection of epigenetic marks
across the genome to constitute the cellular ‘epigenome’.
The study of the epigenome, or epigenomics, refers to
identifying what is literally ‘on’ the genome (the preﬁx
epi- indicating above), and how these phenomena impact
global gene expression, DNA mediated processes, and
subsequently, development. Studying epigenomes
presents more of a challenge because each cell type may
have a different conﬁguration of features and, undoubt-
edly, additional epigenetic marks have yet to be
discovered.
The development of chromatin immunoprecipitation
(ChIP) as an experimental technique was a major break-
through for the ﬁeld of epigenetics (10,11). ChIP allows
for the genomic localization of chromatin associated
proteins. Typically, growing cells are treated with formal-
dehyde to induce protein–DNA crosslinking, followed by
lysis and physical/enzymatic disruption of the chromatin.
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are used to immunoprecipitate the protein–DNA com-
plexes. These antibodies can be speciﬁc to modiﬁed
histones, histone modifying enzymes, transcription
factors, or even modiﬁed nucleotides. Following the
immunoprecipitation, the DNA is isolated from the
protein–DNA complexes for analysis. If a particular
epigenetic feature is localized to a speciﬁc genomic
region, DNA representing that region will be enriched in
the immunoprecipitate. In conjunction with microarray
analysis and more recently, high-throughput (or
next-gen) sequencing, these genomic regions can be
identiﬁed. It is common to represent epigenetic data as
genome ‘tracks’. The output of a next-gen sequencing ex-
periment is millions of short DNA sequences, which are
then aligned to a genome sequence. Sequences that are
enriched in the experimental material (an immuno-
precipitate, say) will occur multiple times and form
visually discernable peaks when represented graphically
in a genome viewer. A commonly used data structure
for this type of track is the ‘wiggle’ format developed for
use with the UCSC Genome Browser (12). Because ﬁles in
this format are usually given a .wig ﬁle extension, we will
hereafter refer to them as ‘WIG ﬁles’. Further advance-
ment of these technologies has enabled genome-wide epi-
genetic analysis and as a result, massive amounts of data
have been generated characterizing genomic localization
of histone modiﬁcations, DNA methylation, smRNA
and miRNA expression, and chromatin accessibility in
numerous organisms and cell types.
With the renewed interest in epigenetics and the meth-
odological advances in whole-genome analysis, in 2007,
the NIH launched the Roadmap Epigenomics Project
(http://nihroadmap.nih.gov/epigenomics/). Among its
aims are the development of reference epigenome maps
from a variety of cell types and unraveling the relation-
ships between the epigenomic landscape and human
disease. Complementary to this effort are the ENCODE
(ENCyclopedia of DNA Elements) project and the corres-
ponding modENCODE project for model organisms
(13,14). Although they are focused on identifying func-
tional DNA elements in the genome, many of these sites
may be epigenetically regulated or participate in epigenetic
regulation. In addition to these large projects, data from
individual laboratory projects are incorporated on an
ongoing basis. The Epigenomics database is being
created as public resource to provide access to these
data. It aims to provide both users familiar with the epi-
genetics ﬁeld and novice users with a simple and intuitive
interface to view, explore, analyze and manipulate these
data.
THE EPIGENOMICS DATABASE
Content in the Epigenomics resource is derived primarily
from data originally submitted to archival databases at the
NCBI, speciﬁcally, the Gene Expression Omnibus (GEO)
and the Sequence Read Archive (SRA) (15,16). Although
originally established to warehouse gene expression data,
GEO has become a general-purpose database for
molecular abundance data from wide variety of experi-
ment types, including those aimed at epigenomics.
In addition to the raw abundance data, extensive meta
data may be provided with GEO submissions in order to
fully describe the biological and experimental context.
In recent years, measurements of molecular abundance
are increasingly being generated by the use of next-gen
sequencing-based approaches. SRA serves as a repository
for raw next-gen sequence data, together with detailed
information on the sequencing instrument and other ex-
perimental variables.
In constructing the new Epigenomics database, we have
identiﬁed the subset of GEO and SRA data that pertain
to epigenomics, subjected them to additional review,
and reorganized them in a fashion that is more useful
for epigenomics researchers. In many cases, data produ-
cers provide WIG ﬁles as part of their GEO submissions,
which allows them to be directly leveraged in the
Epigenomics resource. However, because some submis-
sions either lack WIG ﬁles or have ﬁles based on older
genome assemblies, we have developed a pipeline for
generating epigenetic tracks that primarily uses the pro-
cessed output from the Bowtie aligner (17). The
Epigenomics database currently has data tracks for epi-
genetic features, including histone modiﬁcations, DNA
methylation, chromatin accessibility and expression of
small non-coding RNAs. Data is also available for
several chromatin associated factors such as histone mod-
ifying enzymes, transcription factors, and components
of the core transcriptional machinery. More of these
data type will be included as they become available.
Furthermore, gene expression data for relevant biological
samples will also be included in Epigenomics.
The two fundamental types of database records are
‘studies’ and ‘samples’, both of which are assigned
unique accession numbers (with preﬁxes ESS and ESM,
respectively). A study refers to one or more experiments
with a common set of scientiﬁc aims. Most often an
epigenomic study will correspond to a publication or to
a publicly available data set. For each study, there is a
brief summary of the scientiﬁc design, together with a
listing of the biological samples that were studied and
the epigenetic features examined. Full data source infor-
mation is provided, including the submitter’s institution,
links to the original data submissions in GEO and SRA,
links to literature citations in PubMed and (where avail-
able) links to the full-text articles in PubMed Central.
Each study is associated with a collection of samples.
A sample corresponds to the biological material that was
examined and includes detailed biological source attri-
butes with values drawn from controlled vocabularies.
In order to unify and consistently assign biological attri-
butes, extensive manual curation is performed using
submitted meta data as a foundation. This process may
include examining primary literature and researching
on-line repositories of cell lines, mouse strains, and
tissues. There are over 20 biological attribute ﬁelds avail-
able, including strain, cultivar, ecotype, individual,
gender, age, developmental stage, cell line, cell type,
tissue type, health status and many others.
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2010. As of this writing, it contains 69 studies, 337 samples
and over 1100 data tracks from ﬁve well-studied species
(Table 1). Currently, data tracks for global expression of
micro and small RNAs (194 tracks), histone modiﬁcations
(626 tracks), DNA methylation (128 tracks), chromatin
accessibility (60 tracks) and various chromatin associated
factors (including RNA polymerase, transcription factors,
and various histone modifying enzymes) (140 tracks), are
available among others.
THE EPIGENOMICS WEBSITE
The entry point for exploring these data is the Epi-
genomics home page (www.ncbi.nlm.nih.gov/
epigenomics/). In addition to basic database searching
functionality, it includes links to a series of tutorial docu-
ments that explain how to use the database as well as
scientiﬁc background documents that cover fundamental
topics in epigenetics, such as an introduction to histone
modiﬁcations. The Epigenomics database is part of the
NCBI’s umbrella Entrez search system, which supports
both free-text and ﬁelded queries, together with a
uniform system for representing links between related
records in different databases (18).
To simplify browsing of the database contents, we
have developed a unique Sample Browser tool, which
lists samples in a tabular (spreadsheet-like) display
(Figure 1). The user-conﬁgurable columns correspond
to various biological and experimental attributes while
the rows are the epigenomic samples. The table may be
sorted on any column and the entire table may be
exported in a spreadsheet-compatible format (comma-
separated values). Pre-set ﬁlters provide easy browsing
Figure 1. The Sample Browser interface for navigating samples in the Epigenomics database. Samples can be ﬁltered by free text by using the Term
Filter. Additionally, three pre-set attribute ﬁlters based on species, cell type, or lab (submitting institution) are available. The samples panel displays
samples with detailed biological attributes. This view is customizable and samples can be selected and sorted in this interface. The Sample Browser
toolbar displays a series of icons that provide additional functionality for manipulating samples (from left to right): add record to clipboard, add
record to a collection, remove record (applies to clipboard and collections), view sample information, view on genome, download track data/export
browser data as table, and conﬁgure (allows column selection within the Sample Browser window).
Table 1. Epigenomics database current record holdings
a
Species Studies Samples Tracks
Arabidopsis thaliana 92 1 2 7
Caenorhabditis elegans 52 2 2 7
Drosophila melanogaster 5 18 141
Homo sapiens 29 159 656
Mus musculus 25 117 295
Totals 69
b 337 1146
aHoldings as of 14 October 2010.
bSeveral studies contain data from multiple species.
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free-text ﬁltering feature allows for ﬁne control of the dis-
played samples. Sets of samples may be stored temporarily
using a clipboard feature or saved permanently (with a
free NCBI login) in named collections. The Sample
Browser also serves as a hub for connecting to other
tools that act on sets of samples, speciﬁcally, graphical
rendering and bulk downloading.
One of the most common tasks performed with track
data involves simple inspection of graphical views and
several popular genome browsers have been developed
for this purpose. These tools allow peaks at speciﬁc
features (e.g. promoters and enhancers) to be visualized
and compared across different samples. For example,
Figure 2 shows the differences in the epigenetic marks,
H3K4me3 and H3K27me3, at the developmentally
regulated NANOG gene locus in both embryonic stem
cells and terminally differentiated ﬁbroblasts. The
Epigenomics website provides an easy way for users to
visualize a chosen set of tracks using either the NCBI
Sequence Viewer or the UCSC Genome Browser.
Advanced users may prefer to download track data to
their own systems for local analysis. A bulk downloading
tool may be used to retrieve any chosen set of tracks and
have them delivered in the form of a compressed archive
(ZIP) ﬁle containing the corresponding WIG ﬁles,
together with a ‘read me’ ﬁle with further details about
the samples. Track data for Epigenomics is also available
for download via an anonymous FTP site (ftp://ftp.ncbi
.nih.gov/epigenomics/).
CONCLUSION
The Epigenomics database at NCBI has been established
to serve as a comprehensive public resource for epigenetic
and epigenomic data sets. Data are being collected from
several large scale projects, including the NIH Roadmap
Epigenomics project, ENCODE and modENCODE
projects as well as from smaller single laboratory studies.
With interest in the ﬁeld of epigenomics expanding and the
amount of data increasing dramatically, it is important
that this information be readily available and easily
accessed by all members of the scientiﬁc community.
Epigenomics introduces the Sample Browser, a new and
unique tool at NCBI, which provides an intuitive interface
to the database. We hope to provide users with all levels of
knowledge and expertise in the ﬁeld of epigenetics the
ability to examine and analyze these data.
Figure 2. Visualization of epigenetic features in the vicinity of the NANOG gene locus using the NCBI sequence viewer. Epigenomic data tracks can
be displayed allowing peaks at speciﬁc features to be visualized and compared across different samples. Epigenomic track data are displayed in the
middle (blue) tracks. In this example, the track labels indicate we are comparing the epigenetic marks H3K4me3 and H3K27me3 at the NANOG
gene locus in both H1 embryonic stem cells (top two tracks) and IMR90 ﬁbroblasts (bottom two tracks). Peaks in the tracks indicate areas of the
genome that are enriched for a particular epigenetic feature. The NANOG gene product participates in maintaining stem cell pluripotency. In H1
embryonic stem cells, where the NANOG gene is expressed, the genome tracks show an enrichment of H3K4me3 (a mark associated with actively
transcribed genes), and a lack of H3K27me3 (a mark of repressed chromatin). Conversely, in IMR90 ﬁbroblasts the NANOG gene is no longer
expressed. In this instance, levels of H3K4me3 are reduced, and there is an enrichment of H3K27me3 at the NANOG locus.
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